Valvular heart disease in a patient taking 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy')

Br J Clin Pharmacol. 2012 Sep;74(3):547-8. doi: 10.1111/j.1365-2125.2012.04252.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Hallucinogens / administration & dosage
  • Hallucinogens / adverse effects*
  • Humans
  • Male
  • Mitral Valve Insufficiency / chemically induced*
  • Mitral Valve Insufficiency / pathology
  • N-Methyl-3,4-methylenedioxyamphetamine / administration & dosage
  • N-Methyl-3,4-methylenedioxyamphetamine / adverse effects*
  • Time Factors

Substances

  • Hallucinogens
  • N-Methyl-3,4-methylenedioxyamphetamine